RU2017111649A - Парентеральные композиции и их применение - Google Patents
Парентеральные композиции и их применение Download PDFInfo
- Publication number
- RU2017111649A RU2017111649A RU2017111649A RU2017111649A RU2017111649A RU 2017111649 A RU2017111649 A RU 2017111649A RU 2017111649 A RU2017111649 A RU 2017111649A RU 2017111649 A RU2017111649 A RU 2017111649A RU 2017111649 A RU2017111649 A RU 2017111649A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- composition according
- injection
- representative
- paragraphs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (10)
1. Парентеральная ветеринарная композиция, содержащая нестероидное противовоспалительное средство, антибиотик и не менее 35% диметилсульфооксида.
2. Композиция по п. 1, в которой нестероидное противовоспалительное средство происходит из семейства оксикамов, предпочтительно выбрано из мелоксикама, пироксикама или теноксикама, в частности, мелоксикама.
3. Композиция по п. 1 или 2, в которой антибиотик выбран из антибиотиков фениколы, в частности, из хлорамфеникола, триамфеникола и флорфеникола, в частности, флорфеникола.
4. Композиция по любому из предыдущих пунктов, которая содержит, по меньшей мере, иной растворитель, в частности, по меньшей мере, иной апротонный полярный растворитель, предпочтительно глицеринформаль.
5. Композиция по любому из предыдущих пунктов, которая предназначена для впрыскивания инъецирования не относящемуся к человеку млекопитающему, в частности, домашнему или выращиваемому животному.
6. Композиция по п. 5, где указанным животным является представитель крупного рогатого скота, свинья, овца, представитель семейства псовых или кошачьих, в частности, представитель крупного рогатого скота.
7. Композиция по п. 5, где инъекция производится внутримышечно или подкожно.
8. Композиция по любому из пп. 1–4 для лечения нарушений, вызванных микробными инфекциями, у не относящихся к человеку млекопитающих, в частности, путём инъекции с использованием названной композиции.
9. Композиция по п. 8, где нарушения, вызванные микробными инфекциями, являются расстройствами или болезнями респираторного характера, поражающими нижние или верхние дыхательные пути.
10. Набор ветеринарного назначения, содержащий композицию, охарактеризованную по любому из пп. 1–9, и, при необходимости, по меньшей мере, один компартмент для стерильной обработки.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14306385.7A EP2995297A1 (fr) | 2014-09-09 | 2014-09-09 | Compositions parentérales et leurs utilisations |
EP14306385.7 | 2014-09-09 | ||
PCT/EP2015/070539 WO2016038059A1 (fr) | 2014-09-09 | 2015-09-09 | Compostions parentérales et leurs utilisations |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2017111649A true RU2017111649A (ru) | 2018-10-10 |
RU2017111649A3 RU2017111649A3 (ru) | 2019-02-14 |
RU2744987C2 RU2744987C2 (ru) | 2021-03-17 |
Family
ID=51564609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2017111649A RU2744987C2 (ru) | 2014-09-09 | 2015-09-09 | Парентеральные композиции и их применение |
Country Status (15)
Country | Link |
---|---|
US (1) | US20170304450A1 (ru) |
EP (3) | EP2995297A1 (ru) |
AR (1) | AR101786A1 (ru) |
AU (1) | AU2015314311B2 (ru) |
BR (1) | BR112016028309B1 (ru) |
CA (1) | CA2959936C (ru) |
DK (1) | DK3191080T3 (ru) |
ES (1) | ES2732039T3 (ru) |
HU (1) | HUE045174T2 (ru) |
MX (1) | MX371485B (ru) |
PL (1) | PL3191080T3 (ru) |
PT (1) | PT3191080T (ru) |
RU (1) | RU2744987C2 (ru) |
SI (1) | SI3191080T1 (ru) |
WO (1) | WO2016038059A1 (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230155155A (ko) * | 2022-05-03 | 2023-11-10 | 녹십자수의약품 주식회사 | 마크로라이드 계열 항생제를 유효성분으로 포함하는 개과 동물의 호흡기 질환의 예방 또는 치료용 조성물 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5082863A (en) | 1990-08-29 | 1992-01-21 | Schering Corporation | Pharmaceutical composition of florfenicol |
US20030068339A1 (en) | 2001-10-02 | 2003-04-10 | Phoenix Scientific, Inc. | Veterinary florfenicol formulation that is syringeable under cold weather conditions |
KR20040015623A (ko) | 2002-08-13 | 2004-02-19 | 대한뉴팜(주) | 플로르페니콜을 활성성분으로 함유하는 주사액 조성물 |
EP1568369A1 (en) * | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
MX2009006714A (es) * | 2006-12-19 | 2009-08-31 | Schering Plough Ltd | Formulaciones efervescentes de florfenicol para adicion en sistemas de agua potable. |
US20110105480A1 (en) | 2008-06-24 | 2011-05-05 | Keith Freehauf | Pharmaceutical transdermal compositions and method for treating inflammation in cattle |
FR2936710B1 (fr) * | 2008-10-07 | 2011-01-07 | Ceva Sante Animale | Composition veterinaire antiprolactinique destinee aux ruminants |
NZ588686A (en) * | 2011-01-20 | 2013-07-26 | Bayer New Zealand Ltd | Injectable composition comprising an NSAID and an antibiotic in a non-aqueous solvent for treating a microbial infection in a mammary gland |
-
2014
- 2014-09-09 EP EP14306385.7A patent/EP2995297A1/fr not_active Withdrawn
-
2015
- 2015-09-08 AR ARP150102863A patent/AR101786A1/es active IP Right Grant
- 2015-09-09 PL PL15759475T patent/PL3191080T3/pl unknown
- 2015-09-09 EP EP19158008.3A patent/EP3513781A1/fr not_active Withdrawn
- 2015-09-09 EP EP15759475.5A patent/EP3191080B1/fr active Active
- 2015-09-09 WO PCT/EP2015/070539 patent/WO2016038059A1/fr active Application Filing
- 2015-09-09 SI SI201530786T patent/SI3191080T1/sl unknown
- 2015-09-09 DK DK15759475.5T patent/DK3191080T3/da active
- 2015-09-09 PT PT15759475T patent/PT3191080T/pt unknown
- 2015-09-09 HU HUE15759475A patent/HUE045174T2/hu unknown
- 2015-09-09 CA CA2959936A patent/CA2959936C/fr active Active
- 2015-09-09 US US15/509,730 patent/US20170304450A1/en not_active Abandoned
- 2015-09-09 ES ES15759475T patent/ES2732039T3/es active Active
- 2015-09-09 BR BR112016028309-0A patent/BR112016028309B1/pt active IP Right Grant
- 2015-09-09 RU RU2017111649A patent/RU2744987C2/ru active
- 2015-09-09 MX MX2017003019A patent/MX371485B/es active IP Right Grant
- 2015-09-09 AU AU2015314311A patent/AU2015314311B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2732039T3 (es) | 2019-11-20 |
SI3191080T1 (sl) | 2019-09-30 |
EP3513781A1 (fr) | 2019-07-24 |
WO2016038059A1 (fr) | 2016-03-17 |
BR112016028309A2 (pt) | 2017-08-22 |
AR101786A1 (es) | 2017-01-11 |
RU2744987C2 (ru) | 2021-03-17 |
US20170304450A1 (en) | 2017-10-26 |
RU2017111649A3 (ru) | 2019-02-14 |
EP3191080A1 (fr) | 2017-07-19 |
MX371485B (es) | 2020-01-30 |
PL3191080T3 (pl) | 2019-11-29 |
EP2995297A1 (fr) | 2016-03-16 |
AU2015314311B2 (en) | 2020-11-26 |
HUE045174T2 (hu) | 2019-12-30 |
EP3191080B1 (fr) | 2019-03-20 |
DK3191080T3 (da) | 2019-06-24 |
AU2015314311A1 (en) | 2017-03-23 |
MX2017003019A (es) | 2017-05-30 |
CA2959936C (fr) | 2023-03-14 |
PT3191080T (pt) | 2019-06-28 |
CA2959936A1 (fr) | 2016-03-17 |
BR112016028309B1 (pt) | 2021-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008001868A1 (es) | Compuestos derivados de n-(2-(hetaril)aril)arilsulfonamidas y n-(2-(hetaril)hetaril)arilsulfonamidas; composicion farmaceutica que comprende a dicho compuesto; y uso para el tratamiento de enfermedades inflamatorias del intestino, enfermedad alergica | |
CY1117559T1 (el) | Ενωση ινδολιου και φαρμακευτικη χρηση αυτου | |
BR112014005268A2 (pt) | compostos de amido como moduladores de ror t e usos dos mesmos | |
CL2019003270A1 (es) | Carboxamidas de octa hidrofenantreno - bis y conjugados de proteína. | |
CL2008000180A1 (es) | Sal tosilato de trans-n-etil-3-fluoro-3-[3-fluoro-4-(pirrolidin-1-ilmetil)fenil]ciclobutanocarboxamida; composicion farmaceutica; y uso para el tratamiento de enfermedades tales como depresion, trastornos del sueno, ansiedad y enfermedades del tracto | |
CO6660445A2 (es) | Compuestos heterocíclicos agonistas del receptor ip | |
CL2007003192A1 (es) | Compuestos derivados de arilamidas sustituidas por tiazol u oxazol; composicion farmaceutica; y uso para el tratamiento de una enfermedad del tracto urinario. | |
EA201791451A1 (ru) | 5-[(пиперазин-1-ил)-3-оксо-пропил]-имидазолидин-2,4-дионовые производные в качестве ингибиторов adamts для лечения остеоартрита | |
BR112012002524A2 (pt) | "composto de fórmula, composição, composição para proteger um animal de uma praga parasítica de invertebrados, métodos para controlar uma praga invertebrada e semente tratada" | |
UY30640A1 (es) | Compuestos | |
EA201592086A1 (ru) | Жирная кислота таллового масла для использования в лечении и кормовые добавки и композиции для животных | |
MX2019014935A (es) | Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos. | |
MA54521A (fr) | Dérivés d'oxopyridine substitués | |
EA202190070A1 (ru) | Бициклические ингибиторы гистондеацетилазы | |
CO2017000044A2 (es) | Derivado de 2–acilaminotiazol o su sal | |
DK3432900T3 (da) | Mælkesyrebakteriesammensæting til behandling af bakterielle vaginale infektioner forårsaget af gardnerella vaginalis og, hvis de forefindes, samtidige svampeinfektioner | |
RU2017111649A (ru) | Парентеральные композиции и их применение | |
CR20130401A (es) | Composiciones inyectables para la mastitis que comprende un antiinflamatorio no esteroideo (aine) y un antibiótico en un disolvente no acuoso | |
BR112014011508A2 (pt) | utilização de pelo menos uma protease estável em meio ácido, e, aditivo e composição para alimentação animal para aves vacinadas | |
BR112017016388A2 (pt) | cenicriviroc para o tratamento da fibrose | |
BRPI1009773A2 (pt) | "composições para tratar uma condição alérgica ou asmática" | |
EA201792685A1 (ru) | Фармацевтическая композиция для лечения воспалительных изменений прямой кишки | |
AR074674A1 (es) | Combinacion de sustancias activas mejorada que comprende un antibiotico y un farmaco antiinflamatorio no esteroideo (aine) | |
UY31953A (es) | 3-cianopirrolidinil-fenil-oxazolidinonas como agentes antibacterianos | |
JP1717147S (ja) | 猫用遊具 |